Commercially Available Cannabis (Hemp) Products for Immune Support: A Prospective Observational Study to Evaluate Safety and Effects
This study will be a prospective observation of the use of commercially available hemp and cannabis products marketed for immune support.
• 18 years of age or older
• Able to read and write in English
• Active participants in the Pennsylvania medical marijuana program (for cannabis product users)
• Currently experiencing one or more of the following symptoms due to an acute illness:
‣ Fever or chills
⁃ Cough
⁃ Fatigue
⁃ Muscle or body aches
⁃ Headache
⁃ Sore throat
⁃ Congestion or runny nose
⁃ Nausea or Vomiting
⁃ Diarrhea
• Agrees to consume their chosen hemp or cannabis product (for the cannabis arm) and to not use a different hemp or cannabis product through the duration of the study
• Agrees to continue to abstain from using hemp or cannabis (for the non-cannabis/hemp using arm)
• Must have smart phone or email and access to the internet
• Be able to comply with study requirements including baseline, completion of electronic questionnaires, and study timeline parameters.